HLA-A*0201-restricted peptide vaccine therapy
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for HLA-A*0201-restricted peptide vaccine therapy, covering 2008-05-14 to 2009-12-29. Get the full timeline:
Most recent: Clinical Trial Update: Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer [Phase 1, Phase 2]